ArticleFrontiers in nutrition2025
Relationship between the Chinese visceral adiposity index and gout in individuals with type 2 diabetes mellitus: a cross-sectional population-based study.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and risk factors of hyperuricemia and gout in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.Frontiers in endocrinology · 2026Pooled it
- Decoding the lipid etiology of atherogenic index of plasma and gout: establishing the causal role of triglycerides through NHANES, Mendelian randomization, and network pharmacology.Cardiovascular diabetology. Endocrinology reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Visceral adiposity indices have recently attracted considerable attention in metabolic and cardiovascular research. Here, the link between the Chinese Visceral Adiposity Index (CVAI) and gout in individuals with type 2 diabetes mellitus (T2DM) was investigated. Methods: This cross-sectional analysis evaluated 14,099 adults with T2DM. The CVAI-gout relationship was investigated using restricted cubic spline (RCS) modeling to assess dose-responsiveness. Multivariable logistic regression was applied, with adjustments for demographic and metabolic covariates. Subgroup analyses and interaction tests were performed across clinically relevant strata, and ROC curves were applied to assess the utility of the CVAI in discriminate patients with gout. Results: Among all participants, 5.7% were diagnosed with gout. Higher CVAI values were linked with raised gout incidence (adjusted OR 1.07, 95% CI 1.05-1.09), with RCS models revealing a steadily increasing, positive association between between the CVAI and gout prevalence. After full adjustment, the top CVAI quartile showed a 2.44-fold greater prevalence of gout (95% CI 1.85-3.22) relative to the lowest quartile. Subgroup analyses confirmed consistent associations across various categories. ROC analysis further demonstrated that CVAI had superior discriminative ability for gout compared with traditional obesity indices. Conclusion: This large-sample investigation of Chinese patients with T2DM indicated a strong positive link between the CVAI and gout, suggesting the potential of the CVAI for stratifying metabolic risk in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.